GR3024457T3 - Method and composition for determining the immunological activity of bioactive substances. - Google Patents

Method and composition for determining the immunological activity of bioactive substances.

Info

Publication number
GR3024457T3
GR3024457T3 GR970402095T GR970402095T GR3024457T3 GR 3024457 T3 GR3024457 T3 GR 3024457T3 GR 970402095 T GR970402095 T GR 970402095T GR 970402095 T GR970402095 T GR 970402095T GR 3024457 T3 GR3024457 T3 GR 3024457T3
Authority
GR
Greece
Prior art keywords
bioactive substances
immunological activity
tested
solution
determining
Prior art date
Application number
GR970402095T
Other languages
English (en)
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Ets filed Critical Torf Ets
Publication of GR3024457T3 publication Critical patent/GR3024457T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GR970402095T 1991-10-26 1997-08-14 Method and composition for determining the immunological activity of bioactive substances. GR3024457T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (1)

Publication Number Publication Date
GR3024457T3 true GR3024457T3 (en) 1997-11-28

Family

ID=8207282

Family Applications (3)

Application Number Title Priority Date Filing Date
GR930300100T GR930300100T1 (el) 1991-10-26 1993-10-29
GR940300077T GR940300077T1 (en) 1991-10-26 1994-11-30 Method and composition for determining the immunological activity of bioactive substances.
GR970402095T GR3024457T3 (en) 1991-10-26 1997-08-14 Method and composition for determining the immunological activity of bioactive substances.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
GR930300100T GR930300100T1 (el) 1991-10-26 1993-10-29
GR940300077T GR940300077T1 (en) 1991-10-26 1994-11-30 Method and composition for determining the immunological activity of bioactive substances.

Country Status (23)

Country Link
US (1) US5543300A (el)
EP (2) EP0539610A1 (el)
JP (1) JPH07500905A (el)
AT (1) ATE153763T1 (el)
AU (1) AU678343B2 (el)
BG (1) BG61705B1 (el)
CA (1) CA2122131A1 (el)
CZ (1) CZ100494A3 (el)
DE (3) DE539610T1 (el)
DK (1) DK0609255T3 (el)
ES (1) ES2061424T3 (el)
FI (1) FI941920A0 (el)
GR (3) GR930300100T1 (el)
HK (1) HK1002610A1 (el)
HU (1) HU216863B (el)
LV (1) LV12140B (el)
NO (1) NO941444L (el)
PL (1) PL170592B1 (el)
RO (1) RO114837B1 (el)
RU (1) RU2125727C1 (el)
SG (1) SG72665A1 (el)
SK (1) SK44094A3 (el)
WO (1) WO1993008470A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
EP1115408B1 (en) * 1998-09-23 2006-01-25 Pfeinsmith Limited Oxihumic acid and its use in the treatment of various conditions
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
EP1449535B1 (en) * 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
CA2845931C (en) 2011-09-07 2016-07-12 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
CA2083060A1 (en) * 1991-03-16 1992-09-17 Stanislaw Tolpa Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
RO114837B1 (ro) 1999-07-30
JPH07500905A (ja) 1995-01-26
LV12140B (lv) 1998-12-20
ES2061424T1 (es) 1994-12-16
RU94022481A (ru) 1996-09-27
SK44094A3 (en) 1995-03-08
HU216863B (hu) 1999-09-28
GR940300077T1 (en) 1994-11-30
PL170592B1 (en) 1997-01-31
WO1993008470A1 (en) 1993-04-29
DE69220078T2 (de) 1997-12-04
HK1002610A1 (en) 1998-09-04
FI941920A (fi) 1994-04-25
NO941444L (no) 1994-06-16
HU9401185D0 (en) 1994-07-28
HUT69990A (en) 1995-09-28
NO941444D0 (no) 1994-04-21
FI941920A0 (fi) 1994-04-25
EP0539610A1 (en) 1993-05-05
US5543300A (en) 1996-08-06
DE69220078D1 (de) 1997-07-03
ES2061424T3 (es) 1997-10-01
EP0609255A1 (en) 1994-08-10
BG61705B1 (bg) 1998-03-31
BG98720A (bg) 1995-07-28
GR930300100T1 (el) 1993-10-29
EP0609255B1 (en) 1997-05-28
CA2122131A1 (en) 1993-04-29
AU678343B2 (en) 1997-05-29
DE539610T1 (de) 1993-12-16
ATE153763T1 (de) 1997-06-15
LV12140A (lv) 1998-09-20
CZ100494A3 (en) 1994-11-16
SG72665A1 (en) 2000-05-23
AU2650992A (en) 1993-05-21
DE609255T1 (de) 1995-06-14
DK0609255T3 (da) 1997-12-22
RU2125727C1 (ru) 1999-01-27

Similar Documents

Publication Publication Date Title
DE122007000080I1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzündlicher und viraler hauterkrankungen.
AU9058091A (en) Preparation of nucleic acid samples
GR940300077T1 (en) Method and composition for determining the immunological activity of bioactive substances.
EP0376251A3 (en) An anticoagulant substance obtained from urine
DK0824357T3 (da) Anvendelsen af epidermal vækstfaktor som et gastrointestinalt terapeutisk middel
DE3884680D1 (de) Äusseres Membranprotein F von Pseudomonas aeruginosa.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
Müller Influence of ionizing radiation on the appearance in the serum of rabbits of humoral factors slowing down cell division
ATE4216T1 (de) 3-hydrocarbylthio-2-acyloxypropyl 2trimethylammonioethyl phosphate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK183788A (da) Fremgangsmaade til foroegelse af levedygtigheden af frysetoerrede, maelkesyreproducerende bakteriekulturkoncentrater
DE69025967T2 (de) Aryl- oder Heteroaryl-1-alkyl-pyrrol-2-carbonsäure-Derivate, zur Behandlung von durch Interleukin-1 hervorgerufenen Erkrankungen
DE3861273D1 (de) Taurinderivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
DE69019431T2 (de) Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
JPS5618591A (en) Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
FR2645865B1 (fr) Procede de preparation de la proteine c activee et solution de proteine c activee ainsi obtenue
JPS5722688A (en) Concentration of liquid containing nutrient component
JPS6452792A (en) Production of blood platelet growth factor
ATE13633T1 (de) Verfahren zur herstellung von hochgereinigtem antihaemophiliefaktor.
FR2627487B1 (fr) Nouveau derive de l'acide valproique, procede de preparation de ce compose ainsi que medicament antiepileptique le contenant
DE3578065D1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.